Loading clinical trials...
Loading clinical trials...
The Use of Desferal and Adjuvants for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection: A Randomized Controlled Trial
Conditions
Interventions
Desferal 500 MG Injection
Start Date
June 1, 2020
Primary Completion Date
September 30, 2020
Completion Date
December 31, 2020
Last Updated
May 15, 2020
NCT07278388
NCT07123727
NCT07013903
NCT05040659
NCT06391489
NCT06992401
Lead Sponsor
Hesham Al-Inany
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions